| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Zenalb 4.5% solution for injection 250ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Albumin human 4.5% solution for injection 500ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Zenalb 4.5% solution for injection 500ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Albumin human 20% solution for injection 100ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Zenalb 20% solution for injection 100ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Albumin human 20% solution for injection 50ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Zenalb 20% solution for injection 50ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dolasetron 100mg/5ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dolasetron 100mg/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Anzemet I.V. 100mg/5ml solution for injection ampoules (Amdipharm) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 5ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 5ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 5ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 10ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Amikacin 500mg/2ml solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Amikin 500mg/2ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Amikacin 100mg/2ml solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Amikin 100mg/2ml solution for injection vials (Vianex S.A.) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000units/5ml solution for injection vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Multiparin 25,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Disodium pamidronate 90mg/10ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Disodium pamidronate 90mg/10ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000units/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Monoparin 25,000units/1ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ropivacaine 75mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Naropin 75mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ropivacaine 20mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium tetradecyl sulfate 0.2% solution for injection 5ml vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fibro-Vein 0.2% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium tetradecyl sulfate 0.5% solution for injection 2ml ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fibro-Vein 0.5% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ropivacaine 100mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium tetradecyl sulfate 3% solution for injection 5ml vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fibro-Vein 3% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium tetradecyl sulfate 1% solution for injection 2ml ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fibro-Vein 1% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Naropin 100mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 40mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 40mg/1ml solution for injection ampoules (Alpharma Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 240mg/6ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 240mg/6ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 20mg/2ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Nebcin 20mg/2ml solution for injection vials (King Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 15mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 15mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 15mg/2ml solution for injection ampoules (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 15mg/2ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Interferon alfa-2b (rbe) 60million units/1.2ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| IntronA 60million units/1.2ml solution for injection multidose pens (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fentanyl 500micrograms/10ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fentanyl 500micrograms/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fentanyl 500micrograms/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sublimaze 500micrograms/10ml solution for injection ampoules (Janssen-Cilag Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fentanyl 500micrograms/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Aurum Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Heparin sodium 10,000units/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Monoparin 10,000units/10ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Heparin sodium 125,000units/5ml solution for injection vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Multiparin 125,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000units/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Monoparin 25,000units/5ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ergometrine 500micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ergometrine 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Carnitine 1g/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Carnitor 1g/5ml solution for injection ampoules (Shire Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hydroxyprogesterone 250mg/1ml solution for injection ampoules 3 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Proluton Depot 250mg/1ml solution for injection ampoules (Schering Health Care Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Clomipramine 25mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Anafranil 25mg/2ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Iron dextran 100mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| CosmoFer 100mg/2ml solution for injection ampoules (Pharmacosmos UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Neostigmine 2.5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Neostigmine 2.5mg/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 10% solution for injection 10ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 10% solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 10% solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 10% solution for injection 10ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Robinul-Neostigmine solution for injection 1ml ampoules (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 3mg/10ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 3mg/10ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 3mg/10ml solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 3mg/10ml solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|